| Literature DB >> 31953917 |
Kelly C McInnis1, Eric T Chen2, Jonathan T Finnoff3, Eugene Y Roh4, Joanne Borg Stein1.
Abstract
Management of hip region disorders is challenging. Orthobiologic treatments including platelet rich plasma (PRP), mesenchymal stem cells, and amniotic injectables have gained popularity as promising treatments despite a lack of robust evidence for their effectiveness. We review rationale and current evidence for orthobiologics for three common hip region conditions: hip osteoarthritis, gluteal tendinopathy, and proximal hamstring tendinopathy. Overall, the current state of evidence is extremely limited for orthobiologic treatments and is predominantly relevant to PRP injections. There is currently a lack of data to support the use of mesenchymal stem cells or amniotic injectables in these conditions of the hip.Entities:
Mesh:
Year: 2020 PMID: 31953917 DOI: 10.1002/pmrj.12327
Source DB: PubMed Journal: PM R ISSN: 1934-1482 Impact factor: 2.298